Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells
- PMID: 17624579
- DOI: 10.1007/s11095-007-9362-9
Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells
Abstract
Purpose: We investigated whether gefitinib, an anticancer agent, inhibits phosphatidylcholine (PC) biosynthesis and choline uptake by alveolar epithelial type II cells.
Materials and methods: Uptake of choline and PC biosynthesis were examined in vitro, using human alveolar epithelia-derived cell line A549 and rat alveolar type (AT) II cells as models.
Results: Gefitinib reduced the incorporation of [3H]choline into PC in A549 and rat ATII cells. The uptake of [3H]choline by A549 and rat ATII cells was concentration-dependent, and the Km values were 15.0 and 10-100 microM, respectively. The uptake of [3H]choline by A549 and rat ATII cells was weakly Na+-dependent, and inhibited by hemicholinium-3. RT-PCR revealed expression of choline transporter-like protein (CTL)1 and organic cation transporter (OCT)3 mRNAs in both cells. The choline uptake by A549 and rat ATII cells was strongly inhibited by gefitinib with the IC50 value of 6.77 microM and 10.5 microM, respectively.
Conclusions: Our results demonstrate that gefitinib reduces PC biosynthesis via inhibition of cellular choline uptake by A549 and rat ATII cells, which is mainly mediated by CTL1, resulting in abnormality of lung surfactant that can be one of mechanisms of the interstitial lung disease associated with gefitinib.
Similar articles
-
Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoid-induced acceleration of phosphatidylcholine synthesis via increased choline uptake.Biol Pharm Bull. 2010;33(4):691-6. doi: 10.1248/bpb.33.691. Biol Pharm Bull. 2010. PMID: 20410607
-
Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy.Pharmacol Res. 2013 Oct;76:119-31. doi: 10.1016/j.phrs.2013.07.011. Epub 2013 Aug 13. Pharmacol Res. 2013. PMID: 23948665
-
Effects of halothane on surfactant biosynthesis by rat alveolar type II cells in primary culture.Anesthesiology. 1994 Sep;81(3):668-76. doi: 10.1097/00000542-199409000-00021. Anesthesiology. 1994. PMID: 8092514
-
The ubiquitous choline transporter SLC44A1.Cent Nerv Syst Agents Med Chem. 2012 Jun;12(2):70-81. doi: 10.2174/187152412800792733. Cent Nerv Syst Agents Med Chem. 2012. PMID: 22483272 Review.
-
Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.Biopharm Drug Dispos. 2014 Nov;35(8):431-49. doi: 10.1002/bdd.1892. Epub 2014 Feb 27. Biopharm Drug Dispos. 2014. PMID: 24532461 Review.
Cited by
-
Lipids at the crossroad: Shaping biological membranes heterogeneity defines trafficking pathways.PLoS Biol. 2018 Feb 26;16(2):e2005188. doi: 10.1371/journal.pbio.2005188. eCollection 2018 Feb. PLoS Biol. 2018. PMID: 29481577 Free PMC article.
-
Choline transport links macrophage phospholipid metabolism and inflammation.J Biol Chem. 2018 Jul 20;293(29):11600-11611. doi: 10.1074/jbc.RA118.003180. Epub 2018 Jun 7. J Biol Chem. 2018. PMID: 29880645 Free PMC article.
-
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis.Cells. 2022 Apr 3;11(7):1209. doi: 10.3390/cells11071209. Cells. 2022. PMID: 35406772 Free PMC article. Review.
-
Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1.Exp Biol Med (Maywood). 2019 May;244(8):655-662. doi: 10.1177/1535370219830997. Epub 2019 Feb 18. Exp Biol Med (Maywood). 2019. PMID: 30776907 Free PMC article. Review.
-
The epithelial cholinergic system of the airways.Histochem Cell Biol. 2008 Aug;130(2):219-34. doi: 10.1007/s00418-008-0455-2. Epub 2008 Jun 20. Histochem Cell Biol. 2008. PMID: 18566825 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources